Structure and function of the ARH family of ADP-ribosyl-acceptor hydrolases

DNA Repair

Volumn 23, Issue , 2014, Pages 88-94

  Mashimo, Masato ^a   Kato, Jiro ^a   Moss, Joel ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

ADP ribose acceptor hydrolase; ADP ribosylation; ARH; Cholera toxin; Parthanatos; Tumorigenesis

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; ADP RIBOSYL ACCEPTOR HYDROLASE 1; ADP RIBOSYL ACCEPTOR HYDROLASE 3; ARGININE; BACTERIAL TOXIN; GLYCOSIDASE; HYDROLASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLY(ADP RIBOSE)GLYCOHYDROLASES; UNCLASSIFIED DRUG; ADPRHL2 PROTEIN, HUMAN; ARH1 PROTEIN, MOUSE; CHOLERA TOXIN; LDLRAP1 PROTEIN, HUMAN; POLY ADP-RIBOSE GLYCOHYDROLASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; AMINO ACID SEQUENCE; ARTICLE; CARCINOGENESIS; CATALYSIS; CELL DEATH; CHEMICAL BOND; DNA DAMAGE; ENZYME LOCALIZATION; ENZYME SPECIFICITY; HUMAN; HYDROLYSIS; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; MOUSE;

BACTERIA (MICROORGANISMS); MUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE DIPHOSPHATE RIBOSE; ANIMALS; CHOLERA TOXIN; GLYCOSIDE HYDROLASES; HYDROLYSIS; MICE; N-GLYCOSYL HYDROLASES; OXIDATIVE STRESS; POLY ADENOSINE DIPHOSPHATE RIBOSE;

EID: 84917680186     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2014.03.005     Document Type: Article

References (102)

1. Ueda K., Hayaishi O. ADP-ribosylation. Annu. Rev. Biochem. 1985, 54:73-100.
2. Hassa P.O., Haenni S.S., Elser M., Hottiger M.O. Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?. Microbiol. Mol. Biol. Rev. 2006, 70:789-829.
3. Vaughan M., Moss J. Mono (ADP-ribosyl)transferases and their effects on cellular metabolism. Curr. Top. Cell Regul. 1981, 20:205-246.
4. Iglewski B.H., Kabat D. NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin. Proc. Natl. Acad. Sci. U. S. A. 1975, 72:2284-2288.
5. Pappenheimer A.M. Diphtheria toxin. Annu. Rev. Biochem. 1977, 46:69-94.
6. Cassel D., Pfeuffer T. Mechanism of cholera toxin action: covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system. Proc. Natl. Acad. Sci. U. S. A. 1978, 75:2669-2673.
7. Tamura M., Nogimori K., Murai S., Yajima M., Ito K., Katada T., Ui M., Ishii S. Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry 1982, 21:5516-5522.
8. Moss J., Stanley S.J., Watkins P.A. Isolation and properties of an NAD- and guanidine-dependent ADP-ribosyltransferase from turkey erythrocytes. J. Biol. Chem. 1980, 255:5838-5840.
9. Moss J., Vaughan M. NAD:arginine mono-ADP-ribosyltransferases from animal cells. Methods Enzymol. 1984, 106:430-437.
10. Moss J., Stanley S.J., Oppenheimer N.J. Substrate specificity and partial purification of a stereospecific NAD- and guanidine-dependent ADP-ribosyltransferase from avian erythrocytes. J. Biol. Chem. 1979, 254:8891-8894.
11. Okazaki I.J., Moss J. Characterization of glycosylphosphatidylinositiol-anchored, secreted, and intracellular vertebrate mono-ADP-ribosyltransferases. Annu. Rev. Nutr. 1999, 19:485-509.
12. Seman M., Adriouch S., Haag F., Koch-Nolte F. Ecto-ADP-ribosyltransferases (ARTs): emerging actors in cell communication and signaling. Curr. Med. Chem. 2004, 11:857-872.
13. Okazaki I.J., Moss J. Glycosylphosphatidylinositol-anchored and secretory isoforms of mono-ADP-ribosyltransferases. J. Biol. Chem. 1998, 273:23617-23620.
14. Zolkiewska A., Nightingale M.S., Moss J. Molecular characterization of NAD:arginine ADP-ribosyltransferase from rabbit skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:11352-11356.
15. Okazaki I.J., Kim H.J., Moss J. Cloning and characterization of a novel membrane-associated lymphocyte NAD:arginine ADP-ribosyltransferase. J. Biol. Chem. 1996, 271:22052-22057.
16. Glowacki G., Braren R., Firner K., Nissen M., Kuhl M., Reche P., Bazan F., Cetkovic-Cvrlje M., Leiter E., Haag F., Koch-Nolte F. The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse. Protein Sci. 2002, 11:1657-1670.
17. Moss J., Balducci E., Cavanaugh E., Kim H.J., Konczalik P., Lesma E.A., Okazaki I.J., Park M., Shoemaker M., Stevens L.A., Zolkiewska A. Characterization of NAD:arginine ADP-ribosyltransferases. Mol. Cell Biochem. 1999, 193:109-113.
18. Jones E.M., Baird A. Cell-surface ADP-ribosylation of fibroblast growth factor-2 by an arginine-specific ADP-ribosyltransferase. Biochem. J. 1997, 323(Pt 1):173-177.
19. Saxty B.A., Yadollahi-Farsani M., Upton P.D., Johnstone S.R., MacDermot J. Inactivation of platelet-derived growth factor-BB following modification by ADP-ribosyltransferase. Br. J. Pharmacol. 2001, 133:1219-1226.
20. Paone G., Wada A., Stevens L.A., Matin A., Hirayama T., Levine R.L., Moss J. ADP ribosylation of human neutrophil peptide-1 regulates its biological properties. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:8231-8235.
21. Zolkiewska A., Moss J. Integrin alpha 7 as substrate for a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase on the surface of skeletal muscle cells. J. Biol. Chem. 1993, 268:25273-25276.
22. Seman M., Adriouch S., Scheuplein F., Krebs C., Freese D., Glowacki G., Deterre P., Haag F., Koch-Nolte F. NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 2003, 19:571-582.
23. Frye R.A. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem. Biophys. Res. Commun. 1999, 260:273-279.
24. Hawse W.F., Wolberger C. Structure-based mechanism of ADP-ribosylation by sirtuins. J. Biol. Chem. 2009, 284:33654-33661.
25. Liszt G., Ford E., Kurtev M., Guarente L. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J. Biol. Chem. 2005, 280:21313-21320.
26. Haigis M.C., Mostoslavsky R., Haigis K.M., Fahie K., Christodoulou D.C., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Karow M., Blander G., Wolberger C., Prolla T.A., Weindruch R., Alt F.W., Guarente L. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 2006, 126:941-954.
27. Tsang A.W., Escalante-Semerena J.C. CobB, a new member of the SIR2 family of eucaryotic regulatory proteins, is required to compensate for the lack of nicotinate mononucleotide: 5,6-dimethylbenzimidazole phosphoribosyltransferase activity in cobT mutants during cobalamin biosynthesis in Salmonella typhimurium LT2. J. Biol. Chem. 1998, 273:31788-31794.
28. Choi M.M., Huh J.W., Yang S.J., Cho E.H., Choi S.Y., Cho S.W. Identification of ADP-ribosylation site in human glutamate dehydrogenase isozymes. FEBS Lett. 2005, 579:4125-4130.
29. Kleine H., Poreba E., Lesniewicz K., Hassa P.O., Hottiger M.O., Litchfield D.W., Shilton B.H., Luscher B. Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation. Mol. Cell 2008, 32:57-69.
30. Di Paola S., Micaroni M., Di Tullio G., Buccione R., Di Girolamo M. PARP16/ARTD15 is a novel endoplasmic-reticulum-associated mono-ADP-ribosyltransferase that interacts with, and modifies karyopherin-ss1. PLoS One 2012, 7:e37352.
31. Gibson B.A., Kraus W.L. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat. Rev. Mol. Cell Biol. 2012, 13:411-424.
32. Ame J.C., Spenlehauer C., de Murcia G. The PARP superfamily. Bioessays 2004, 26:882-893.
33. Schreiber V., Dantzer F., Ame J.C., de Murcia G. Poly(ADP-ribose): novel functions for an old molecule. Nat. Rev. Mol. Cell Biol. 2006, 7:517-528.
34. Rouleau M., Patel A., Hendzel M.J., Kaufmann S.H., Poirier G.G. PARP inhibition: PARP1 and beyond. Nat. Rev. Cancer 2010, 10:293-301.
35. + into a nuclear signal. Genes Dev. 2005, 19:1951-1967.
36. Heeres J.T., Hergenrother P.J. Poly(ADP-ribose) makes a date with death. Curr. Opin. Chem. Biol. 2007, 11:644-653.
37. Leung A.K., Vyas S., Rood J.E., Bhutkar A., Sharp P.A., Chang P. Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol. Cell 2011, 42:489-499.
38. Boehler C., Gauthier L.R., Mortusewicz O., Biard D.S., Saliou J.M., Bresson A., Sanglier-Cianferani S., Smith S., Schreiber V., Boussin F., Dantzer F. Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:2783-2788.
39. Ame J.C., Rolli V., Schreiber V., Niedergang C., Apiou F., Decker P., Muller S., Hoger T., Menissier-de Murcia J., de Murcia G. PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J. Biol. Chem. 1999, 274:17860-17868.
40. Langelier M.F., Planck J.L., Roy S., Pascal J.M. Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP-1. Science 2012, 336:728-732.
41. Kawaichi M., Ueda K., Hayaishi O. Multiple autopoly(ADP-ribosyl)ation of rat liver poly(ADP-ribose) synthetase. Mode of modification and properties of automodified synthetase. J. Biol. Chem. 1981, 256:9483-9489.
42. Ali A.A., Timinszky G., Arribas-Bosacoma R., Kozlowski M., Hassa P.O., Hassler M., Ladurner A.G., Pearl L.H., Oliver A.W. The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks. Nat. Struct. Mol. Biol. 2012, 19:685-692.
43. Altmeyer M., Messner S., Hassa P.O., Fey M., Hottiger M.O. Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites. Nucl. Acids Res. 2009, 37:3723-3738.
44. Ogata N., Ueda K., Kagamiyama H., Hayaishi O. ADP-ribosylation of histone H1. Identification of glutamic acid residues 2, 14, and the COOH-terminal lysine residue as modification sites. J. Biol. Chem. 1980, 255:7616-7620.
45. D'Amours D., Desnoyers S., D'Silva I., Poirier G.G. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J. 1999, 342(Pt 2):249-268.
46. Jungmichel S., Rosenthal F., Altmeyer M., Lukas J., Hottiger M.O., Nielsen M.L. Proteome-wide identification of poly(ADP-ribosyl)ation targets in different genotoxic stress responses. Mol. Cell 2013, 52:272-285.
47. Gagne J.P., Pic E., Isabelle M., Krietsch J., Ethier C., Paquet E., Kelly I., Boutin M., Moon K.M., Foster L.J., Poirier G.G. Quantitative proteomics profiling of the poly(ADP-ribose)-related response to genotoxic stress. Nucl. Acids Res. 2012, 40:7788-7805.
48. Krupitza G., Cerutti P. ADP-ribosylation of ADPR-transferase and topoisomerase I in intact mouse epidermal cells JB6. Biochemistry 1989, 28:2034-2040.
49. Ogata N., Ueda K., Kawaichi M., Hayaishi O. Poly(ADP-ribose) synthetase, a main acceptor of poly(ADP-ribose) in isolated nuclei. J. Biol. Chem. 1981, 256:4135-4137.
50. Chapman J.D., Gagne J.P., Poirier G.G., Goodlett D.R. Mapping PARP-1 auto-ADP-ribosylation sites by liquid chromatography-tandem mass spectrometry. J. Proteome Res. 2013, 12:1868-1880.
51. Masson M., Niedergang C., Schreiber V., Muller S., Menissier-de Murcia J., de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol. Cell Biol. 1998, 18:3563-3571.
52. Pacher P., Szabo C. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc. Drug Rev. 2007, 25:235-260.
53. Komjati K., Besson V.C., Szabo C. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma. Curr. Drug Targets CNS Neurol. Disord. 2005, 4:179-194.
54. Andrabi S.A., Kim N.S., Yu S.W., Wang H., Koh D.W., Sasaki M., Klaus J.A., Otsuka T., Zhang Z., Koehler R.C., Hurn P.D., Poirier G.G., Dawson V.L., Dawson T.M. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18308-18313.
55. Lee Y., Karuppagounder S.S., Shin J.H., Lee Y.I., Ko H.S., Swing D., Jiang H., Kang S.U., Lee B.D., Kang H.C., Kim D., Tessarollo L., Dawson V.L., Dawson T.M. Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss. Nat. Neurosci. 2013, 16:1392-1400.
56. Mandir A.S., Przedborski S., Jackson-Lewis V., Wang Z.Q., Simbulan-Rosenthal C.M., Smulson M.E., Hoffman B.E., Guastella D.B., Dawson V.L., Dawson T.M. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:5774-5779.
57. Masutani M., Suzuki H., Kamada N., Watanabe M., Ueda O., Nozaki T., Jishage K., Watanabe T., Sugimoto T., Nakagama H., Ochiya T., Sugimura T. Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:2301-2304.
58. Wang Y., Kim N.S., Haince J.F., Kang H.C., David K.K., Andrabi S.A., Poirier G.G., Dawson V.L., Dawson T.M. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Sci. Signal. 2011, 4:ra20.
59. Szabo C., Zingarelli B., O'Connor M., Salzman A.L. DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:1753-1758.
60. Ha H.C., Snyder S.H. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:13978-13982.
61. Yu S.W., Andrabi S.A., Wang H., Kim N.S., Poirier G.G., Dawson T.M., Dawson V.L. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18314-18319.
62. Yu S.W., Wang H., Poitras M.F., Coombs C., Bowers W.J., Federoff H.J., Poirier G.G., Dawson T.M., Dawson V.L. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002, 297:259-263.
63. Hatakeyama K., Nemoto Y., Ueda K., Hayaishi O. Purification and characterization of poly(ADP-ribose) glycohydrolase. Different modes of action on large and small poly(ADP-ribose). J. Biol. Chem. 1986, 261:14902-14911.
64. Miwa M., Sugimura T. Splitting of the ribose-ribose linkage of poly(adenosine diphosphate-robose) by a calf thymus extract. J. Biol. Chem. 1971, 246:6362-6364.
65. Niere M., Mashimo M., Agledal L., Dolle C., Kasamatsu A., Kato J., Moss J., Ziegler M. ADP-ribosylhydrolase 3 (ARH3), not poly(ADP-ribose) glycohydrolase (PARG) isoforms, is responsible for degradation of mitochondrial matrix-associated poly(ADP-ribose). J. Biol. Chem. 2012, 287:16088-16102.
66. Meyer-Ficca M.L., Meyer R.G., Coyle D.L., Jacobson E.L., Jacobson M.K. Human poly(ADP-ribose) glycohydrolase is expressed in alternative splice variants yielding isoforms that localize to different cell compartments. Exp. Cell Res. 2004, 297:521-532.
67. Winstall E., Affar E.B., Shah R., Bourassa S., Scovassi A.I., Poirier G.G. Poly(ADP-ribose) glycohydrolase is present and active in mammalian cells as a 110-kDa protein. Exp. Cell Res. 1999, 246:395-398.
68. Meyer R.G., Meyer-Ficca M.L., Whatcott C.J., Jacobson E.L., Jacobson M.K. Two small enzyme isoforms mediate mammalian mitochondrial poly(ADP-ribose) glycohydrolase (PARG) activity. Exp. Cell Res. 2007, 313:2920-2936.
69. Koh D.W., Lawler A.M., Poitras M.F., Sasaki M., Wattler S., Nehls M.C., Stoger T., Poirier G.G., Dawson V.L., Dawson T.M. Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:17699-17704.
70. Karras G.I., Kustatscher G., Buhecha H.R., Allen M.D., Pugieux C., Sait F., Bycroft M., Ladurner A.G. The macro domain is an ADP-ribose binding module. EMBO J. 2005, 24:1911-1920.
71. Kustatscher G., Hothorn M., Pugieux C., Scheffzek K., Ladurner A.G. Splicing regulates NAD metabolite binding to histone macroH2A. Nat. Struct. Mol. Biol. 2005, 12:624-625.
72. Sharifi R., Morra R., Appel C.D., Tallis M., Chioza B., Jankevicius G., Simpson M.A., Matic I., Ozkan E., Golia B., Schellenberg M.J., Weston R., Williams J.G., Rossi M.N., Galehdari H., Krahn J., Wan A., Trembath R.C., Crosby A.H., Ahel D., Hay R., Ladurner A.G., Timinszky G., Williams R.S., Ahel I. Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease. EMBO J. 2013, 32:1225-1237.
73. Feijs K.L., Forst A.H., Verheugd P., Luscher B. Macrodomain-containing proteins: regulating new intracellular functions of mono(ADP-ribosyl)ation. Nat. Rev. Mol. Cell Biol. 2013, 14:443-451.
74. Rosenthal F., Feijs K.L., Frugier E., Bonalli M., Forst A.H., Imhof R., Winkler H.C., Fischer D., Caflisch A., Hassa P.O., Luscher B., Hottiger M.O. Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases. Nat. Struct. Mol. Biol. 2013, 20:502-507.
75. Jankevicius G., Hassler M., Golia B., Rybin V., Zacharias M., Timinszky G., Ladurner A.G. A family of macrodomain proteins reverses cellular mono-ADP-ribosylation. Nat. Struct. Mol. Biol. 2013, 20:508-514.
76. Oka S., Kato J., Moss J. Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase. J. Biol. Chem. 2006, 281:705-713.
77. Mueller-Dieckmann C., Kernstock S., Lisurek M., von Kries J.P., Haag F., Weiss M.S., Koch-Nolte F. The structure of human ADP-ribosylhydrolase 3 (ARH3) provides insights into the reversibility of protein ADP-ribosylation. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:15026-15031.
78. Moss J., Stanley S.J., Nightingale M.S., Murtagh J.J., Monaco L., Mishima K., Chen H.C., Williamson K.C., Tsai S.C. Molecular and immunological characterization of ADP-ribosylarginine hydrolases. J. Biol. Chem. 1992, 267:10481-10488.
79. Moss J., Jacobson M.K., Stanley S.J. Reversibility of arginine-specific mono(ADP-ribosyl)ation: identification in erythrocytes of an ADP-ribose-l-arginine cleavage enzyme. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:5603-5607.
80. Moss J., Oppenheimer N.J., West R.E., Stanley S.J. Amino acid specific ADP-ribosylation: substrate specificity of an ADP-ribosylarginine hydrolase from turkey erythrocytes. Biochemistry 1986, 25:5408-5414.
81. Ono T., Kasamatsu A., Oka S., Moss J. The 39-kDa poly(ADP-ribose) glycohydrolase ARH3 hydrolyzes O-acetyl-ADP-ribose, a product of the Sir2 family of acetyl-histone deacetylases. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16687-16691.
82. Kasamatsu A., Nakao M., Smith B.C., Comstock L.R., Ono T., Kato J., Denu J.M., Moss J. Hydrolysis of O-acetyl-ADP-ribose isomers by ADP-ribosylhydrolase 3. J. Biol. Chem. 2011, 286:21110-21117.
83. Liou G.G., Tanny J.C., Kruger R.G., Walz T., Moazed D. Assembly of the SIR complex and its regulation by O-acetyl-ADP-ribose, a product of NAD-dependent histone deacetylation. Cell 2005, 121:515-527.
84. +-dependent deacetylases. J. Biol. Chem. 2002, 277:12632-12641.
85. Grubisha O., Rafty L.A., Takanishi C.L., Xu X., Tong L., Perraud A.L., Scharenberg A.M., Denu J.M. Metabolite of SIR2 reaction modulates TRPM2 ion channel. J. Biol. Chem. 2006, 281:14057-14065.
86. + metabolites and modulates cellular redox. J. Biol. Chem. 2009, 284:11256-11266.
87. Konczalik P., Moss J. Identification of critical, conserved vicinal aspartate residues in mammalian and bacterial ADP-ribosylarginine hydrolases. J. Biol. Chem. 1999, 274:16736-16740.
88. Takada T., Iida K., Moss J. Cloning and site-directed mutagenesis of human ADP-ribosylarginine hydrolase. J. Biol. Chem. 1993, 268:17837-17843.
89. Kato J., Zhu J., Liu C., Moss J. Enhanced sensitivity to cholera toxin in ADP-ribosylarginine hydrolase-deficient mice. Mol. Cell Biol. 2007, 27:5534-5543.
90. Kato J., Zhu J., Liu C., Stylianou M., Hoffmann V., Lizak M.J., Glasgow C.G., Moss J. ADP-ribosylarginine hydrolase regulates cell proliferation and tumorigenesis. Cancer Res. 2011, 71:5327-5335.
91. Shim B., Pacheco-Rodriguez G., Kato J., Darling T.N., Vaughan M., Moss J. Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models. Eur. Respir. Rev. 2013, 22:302-311.
92. Niere M., Kernstock S., Koch-Nolte F., Ziegler M. Functional localization of two poly(ADP-ribose)-degrading enzymes to the mitochondrial matrix. Mol. Cell Biol. 2008, 28:814-824.
93. Mashimo M., Kato J., Moss J. ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:18964-18969.
94. Scovassi A.I. Mitochondrial poly(ADP-ribosylation): from old data to new perspectives. FASEB J. 2004, 18:1487-1488.
95. Haigis M.C., Guarente L.P. Mammalian sirtuins - emerging roles in physiology, aging, and calorie restriction. Genes Dev. 2006, 20:2913-2921.
96. Yu S.W., Wang Y., Frydenlund D.S., Ottersen O.P., Dawson V.L., Dawson T.M. Outer mitochondrial membrane localization of apoptosis-inducing factor: mechanistic implications for release. ASN Neuro 2009, 1:275-281.
97. Patel N.S., Cortes U., Di Poala R., Mazzon E., Mota-Filipe H., Cuzzocrea S., Wang Z.Q., Thiemermann C. Mice lacking the 110-kD isoform of poly(ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury. J. Am. Soc. Nephrol. 2005, 16:712-719.
98. Cuzzocrea S., Di Paola R., Mazzon E., Cortes U., Genovese T., Muia C., Li W., Xu W., Li J.H., Zhang J., Wang Z.Q. PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion. FASEB J. 2005, 19:558-566.
99. Barkauskaite E., Brassington A., Tan E.S., Warwicker J., Dunstan M.S., Banos B., Lafite P., Ahel M., Mitchison T.J., Ahel I., Leys D. Visualization of poly(ADP-ribose) bound to PARG reveals inherent balance between exo- and endo-glycohydrolase activities. Nat. Commun. 2013, 4:2164.
100. Braun S.A., Panzeter P.L., Collinge M.A., Althaus F.R. Endoglycosidic cleavage of branched polymers by poly(ADP-ribose) glycohydrolase. Eur. J. Biochem. 1994, 220:369-375.
101. Brochu G., Duchaine C., Thibeault L., Lagueux J., Shah G.M., Poirier G.G. Mode of action of poly(ADP-ribose) glycohydrolase. Biochim. Biophys. Acta 1994, 1219:342-350.
102. Uchida K., Suzuki H., Maruta H., Abe H., Aoki K., Miwa M., Tanuma S. Preferential degradation of protein-bound (ADP-ribose)n by nuclear poly(ADP-ribose) glycohydrolase from human placenta. J. Biol. Chem. 1993, 268:3194-3200.